Picture of SurModics logo

SRDX SurModics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Surmodics Inc expected to post earnings of 63  cents a share - Earnings Preview

* Surmodics Inc  SRDX.OQ   SRDX.O  is expected to show a rise in
quarterly revenue when it reports results on April 28.
* The Eden Prairie, Minnesota-based company is expected to
report  a 44.4% increase in revenue to $32.955 million from
$22.82 million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data.​​
​* Refinitiv's mean analyst estimate for Surmodics Inc is for
earnings of 63 cents per share. For the same quarter last year,
the company reported earnings of 4 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts had fallen by
about 28.6% in the last three months.​
* Wall Street's median 12-month price target for Surmodics Inc
is $73​, about 20.3% above​ its last closing price
of $58.20. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  -0.08       -0.09      0.02      Beat    122.2
 Sep. 30 2020  -0.07       -0.08      -0.18     Missed  -125
 Jun. 30 2020  0.17        0.19       0.21      Beat    8.6​
 Mar. 31 2020  -0.13       -0.11      0.04      Beat    137.5
 Dec.          -0.08​      -0.08      0.05      Beat    162.5​
 31​ 2019​                                              
 Sep. 30 2019  0.37        0.37       0.37      Met     0.9​
 Jun. 30 2019  0.05        0.05       0.15      Beat    200
 Mar. 31 2019  -0.04       -0.02      0.07      Beat    400
 This summary was machine generated April 26 at 13:02 GMT.  All
figures in US dollars unless otherwise stated

Recent news on SurModics

See all news